A Comparison of Interferon-γ and IP-10 for the Diagnosis of Tuberculosis

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Pediatrics

• Publication date

  2014-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1542/peds.2014-1570PMID 25422019
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Beyond the IFN-&ggr; horizon: biomarkers for immunodiagnosis of infection with Mycobacterium tuberculosis

  2014cited by this paper
• Cytokine responses to quantiferon peptides in pediatric tuberculosis: a pilot study.

  2014cited by this paper
• Perspectives in implementing standardized case definitions for tuberculosis research involving children in a low-income, high-burden setting.

  2013cited by this paper
• Utility of Host Markers Detected in Quantiferon Supernatants for the Diagnosis of Tuberculosis in Children in a High-Burden Setting

  2013cited by this paper
• Interferon gamma and interferon gamma inducible protein-10 in detecting tuberculosis infection.

  2012cited by this paper
• IP-10 release assays in the diagnosis of tuberculosis infection: current status and future directions

  2012cited by this paper
• Evaluation of tuberculosis diagnostics in children: 1. Proposed clinical case definitions for classification of intrathoracic tuberculosis disease. Consensus from an expert panel.

  2012cited by this paper
• Factors Associated with the Performance of a Blood-Based Interferon-γ Release Assay in Diagnosing Tuberculosis

  2012cited by this paper
• Use of tuberculin skin test, IFN-&ggr; release assays and IFN-&ggr;-induced protein-10 to identify children with TB infection

  2012cited by this paper
• QuantiFERON®-TB Gold In-Tube Performance for Diagnosing Active Tuberculosis in Children and Adults in a High Burden Setting

  2012cited by this paper
• A Simple Method to Quantitate IP-10 in Dried Blood and Plasma Spots

  2012cited by this paper
• IP-10 is an additional marker for tuberculosis (TB) detection in HIV-infected persons in a low-TB endemic country.

  2012cited by this paper
• Diagnostic Value of Interferon- gamma Release Assays (QuantiFERON-TB Gold® In Tube) in Childhood Tuberculosis

  2012cited by this paper
• Current understanding of the immune response to tuberculosis in children

  2012cited by this paper
• Interferon-gamma inducible protein 10 as a biomarker for active tuberculosis and latent tuberculosis infection in children: A case–control study

  2012cited by this paper
• Evaluation of tuberculosis diagnostics in children: 2. Methodological issues for conducting and reporting research evaluations of tuberculosis diagnostics for intrathoracic tuberculosis in children. Consensus from an expert panel.

  2012cited by this paper
• Interferon-gamma release assays and childhood tuberculosis: systematic review and meta-analysis.

  2011cited by this paper
• IP-10 response to RD1 antigens might be a useful biomarker for monitoring tuberculosis therapy

  2011cited by this paper
• Interferon-gamma release assays and childhood tuberculosis: systematic review and meta-analysis [Review article].

  2011cited by this paper
• Can Interferon-Gamma or Interferon-Gamma-Induced-Protein-10 Differentiate Tuberculosis Infection and Disease in Children of High Endemic Areas?

  2011cited by this paper
• The Utility of an Interferon Gamma Release Assay for Diagnosis of Latent Tuberculosis Infection and Disease in Children: A Systematic Review and Meta-analysis

  2011cited by this paper
• IFN-gamma, but not IP-10, MCP-2 or IL-2 response to RD1 selected peptides associates to active tuberculosis.

  2010cited by this paper
• Malnutrition and Helminth Infection Affect Performance of an Interferon γ–Release Assay

  2010cited by this paper
• Interferon-&ggr; release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis

  2010cited by this paper
• Is IP-10 an Accurate Marker for Detecting M. tuberculosis-Specific Response in HIV-Infected Persons?

  2010cited by this paper
• Indeterminate interferon-gamma release assay results in children.

  2010cited by this paper
• Diagnosis of pulmonary tuberculosis in children: new advances

  2010cited by this paper
• The Likelihood of an Indeterminate Test Result from a Whole-Blood Interferon-&ggr; Release Assay for the Diagnosis of Mycobacterium tuberculosis Infection in Children Correlates With Age and Immune Status

  2009cited by this paper
• Chemokine IP-10: an adjunct marker for latent tuberculosis infection in children.

  2009cited by this paper
• The Impact of HIV Infection and CD4 Cell Count on the Performance of an Interferon Gamma Release Assay in Patients with Pulmonary Tuberculosis

  2009cited by this paper
• Improving T-Cell Assays for the Diagnosis of Latent TB Infection: Potential of a Diagnostic Test Based on IP-10

  2008cited by this paper
• Is IP-10 a Better Biomarker for Active and Latent Tuberculosis in Children than IFNγ?

  2008cited by this paper
• Performance of an interferon-gamma release assay for diagnosing latent tuberculosis infection in children

  2007cited by this paper
• Effect of age, polymicrobial disease, and maternal HIV status on treatment response and cause of severe pneumonia in South African children: a prospective descriptive study.

  2007cited by this paper
• Comparison of a whole blood interferon-gamma assay with tuberculin skin testing for the detection of tuberculosis infection in hospitalized children in rural India.

  2007cited by this paper
• Specific Detection of Tuberculosis Infection: An Interferon-γ–based Assay Using New Antigens

  2004cited by this paper
• Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens.

  2004cited by this paper
• Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative.

  2004cited by this paper
• Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative

  2003cited by this paper
• Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative.

  2003cited by this paper

• Interferon (IFN)-gamma (γ) inducible protein 10 (IP-10) in the diagnosis of latent and active tuberculosis in Bacille Calmette Guerin (BCG)-vaccinated pediatric population

  2025cites this paper
• IP-10 for the Diagnosis and Treatment Monitoring of Tuberculosis in Children

  2024cites this paper
• Alternative biomarkers of tuberculosis infection in patients with immune-mediated inflammatory diseases

  2023cites this paper
• Utility of interferon-gamma releasing assay for the diagnosis of active tuberculosis in children: A systematic review and meta-analysis.

  2023cites this paper
• Diagnostic Value of IP-10 Level in Plasma and Bronchoalveolar Lavage Fluid in Children with Tuberculosis and Other Lung Diseases

  2022cites this paper
• Screening tests for active pulmonary tuberculosis in children

  2020cites this paper
• Interferon-g-Inducible Protein 10 for Diagnosis of Tuberculosis in Children

  2020cites this paper
• IP-10 for the diagnosis of tuberculosis in children

  2019cites this paper
• Accumulate evidence for IP-10 in diagnosing pulmonary tuberculosis

  2019cites this paper
• Risk Factors for Indeterminate Interferon-Gamma Release Assay for the Diagnosis of Tuberculosis in Children—A Systematic Review and Meta-Analysis

  2019cites this paper
• Diagnostic accuracy of interferon-gamma-induced protein 10 for differentiating active tuberculosis from latent tuberculosis: A meta-analysis

  2019cites this paper
• Performance of the QuantiFERON-TB Gold Assay Among HIV-infected Children With Active Tuberculosis in France

  2017cites this paper
• Unique Chemokine Profiles of Lung Tissues Distinguish Post-chemotherapeutic Persistent and Chronic Tuberculosis in a Mouse Model

  2017influential citation
• Cytokine/chemokine secretion for detecting tuberculosis in quantiferon supernatants from HIV+ and HIV- children.

  2017cites this paper
• Multiple cytokines for the detection of Mycobacterium tuberculosis infection in children with tuberculosis.

  2017cites this paper
• European shortage of purified protein derivative and its impact on tuberculosis screening practices.

  2016cites this paper
• The Use of Interferon Gamma Inducible Protein 10 as a Potential Biomarker in the Diagnosis of Latent Tuberculosis Infection in Uganda

  2016cites this paper
• Added Value of IP-10 as a Read-Out of Mycobacterium tuberculosis

  2016cites this paper
• Mapping of Mycobacterium tuberculosis Complex Genetic Diversity Profiles in Tanzania and Other African Countries

  2016cites this paper
• Tuberculosis in infants: a retrospective study in China

  2016cites this paper
• What steps do we need to take to improve diagnosis of tuberculosis in children?

  2015cites this paper
• New Diagnostics for Childhood Tuberculosis.

  2015cites this paper
• Validity of Antibodies in Lymphocyte Supernatant in Diagnosing Tuberculosis in Severely Malnourished Children Presenting with Pneumonia

  2015cites this paper
• Regulation network of serum cytokines induced by tuberculosis-specific antigens reveals biomarkers for tuberculosis diagnosis.

  2015cites this paper